Gainesville, United States
Sarkis Clinical Trials is a renowned research facility with a slogan that encapsulates its mission of empowerment through comprehensive mental and medical research for all ages. Since its founding in 1998, the organization has been dedicated to advancing treatment options for children, adolescents, and adults with various mental and medical illnesses. Its focus areas include borderline personality disorder, depression, intermittent explosive disorder, migraines, post-traumatic stress disorder, schizophrenia, and pediatric migraine.
Operating at the forefront of the Care Economy, Health Care, and Health and Wellness industries, Sarkis Clinical Trials is headquartered in the United States and serves as a pivotal player in advancing medical and mental healthcare practices.
Despite its impactful contributions to the healthcare sector, the latest investment details of Sarkis Clinical Trials, including the amount and investors involved, are not publicly disclosed at this time. However, the facility remains responsive to inquiries through multiple channels, including phone, email, and online applications.
With a consistent focus on improving mental and medical research and treatment, Sarkis Clinical Trials continues to position itself as a vital entity in addressing the evolving healthcare needs of individuals across different age groups.
